On the co-production of research: why we should say what we mean, mean what we say, and learn as we go by Holmes, Bev J.
On	the	co-production	of	research:	why	we	should
say	what	we	mean,	mean	what	we	say,	and	learn	as
we	go
Researchers	are	increasingly	encouraged	to	“co-produce”	or	“co-create”	their	research,	particularly
if	it	is	to	have	that	much-prized	impact.	But	what	exactly	does	this	really	mean?	Bev	J.
Holmes	defines	co-production	as	the	collaboration	between	researchers	and	others	with	a	stake	in
a	project	in	its	governance,	priority-setting,	conducting	of	research,	and	knowledge	translation.
Once	what	is	meant	by	co-production	is	clearly	outlined,	it	is	equally	important	to	address	the	many
challenges	of	optimising	participants’	contributions,	and	also	to	commit	to	learning	throughout	the
process	of	co-producing	research.
The	co-production	or	co-creation	of	research	is	not	new.	Action-based	research	traditions	can	lay	claim	to	a	long
history,	but	are	those	of	us	involved	in	co-production	doing	enough	to	understand	what	it	means?
In	their	work	on	public	involvement,	Antoine	Boivin	et	al	(2014)	note	there	is	such	widespread	support	for	the
rhetoric	of	co-production	that	we	may	dismiss	(and	I	would	add,	not	even	acknowledge)	the	tensions	that	arise
when	professionals	and	lay	people	work	together.	Co-production	in	health	research	is	similar.	We	need	to	work
harder	to	say	what	we	mean,	mean	what	we	say,	and	learn	as	we	go.
Say	what	we	mean
Co-production	is	easy	enough	to	say,	but	what	does	it	actually	mean?	I	don’t	often	hear	it	defined,	perhaps
because	it	sounds	obvious.	When	pushed,	people	may	describe	it	as	partnership	or	collaboration.	At	a	workshop
at	the	2017	Global	Implementation	Conference,	we	defined	co-production	as	collaboration	in	governance,	priority-
setting,	conducting	research	and/or	knowledge	translation.	In	turn,	we	defined	collaboration	according	to	the
International	Association	of	Public	Participation’s	public	participation	spectrum.	We	noted	that	co-production
involves	researchers	and	others	with	a	stake	in	the	project:	citizens,	patients,	health	care	providers,	and/or	health
care	decision	and	policymakers.
The	important	piece	in	all	of	the	above	is	shared	decision-making.	But	operationalising	the	“co”	in	co-production	–
a	prefix	implying	joint,	mutual,	in	common	–	is	not	an	easy	task.	Is	co-production	the	appropriate	model	for	the
project	at	hand?	It	isn’t	always;	the	other	elements	on	the	spectrum	(informing,	consulting,	involving,	empowering)
are	just	as	valid,	depending	on	the	situation.	But	they	mean	different	things.	The	message	here	is	that	definitions
–	or	lack	thereof	–	have	significant	implications	for	action,	discussed	next.
Mean	what	we	say
Committing	to	co-creation	–	and	all	it	implies	with	regard	to	shared	decision-making	–	means	acknowledging	that
co-production	is	challenging:	it	requires	role	clarity,	attention	to	power	imbalances,	difficult	discussions	about
research	rigour	versus	research	relevance,	and	constant	monitoring	(Holmes	et	al,	2016).	It	also	means	putting	in
place	the	mechanisms	to	support	it.
Boivin	and	colleagues	note	three	areas	for	attention:
Credibility	–	participants	need	to	learn	each	other’s	language	and	be	seen	as	valued	and	relevant	sources
of	knowledge	for	each	other.
Legitimacy	–	participants	need	to	be	clear	on	whose	behalf	they	speak	(e.g.	people	in	the	same	profession,
users	of	a	particular	service,	patients	with	the	same	condition,	employees	in	a	specific	organisation)	and	be
supported	to	do	so.
Power	–	all	participants	must	be	able	to	influence	decisions.
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Practical	steps	can	be	taken	in	all	these	areas.	For	example	credibility	comes	from	participants’	experience	and
expertise,	but	can	be	built	through	access	to	additional	information	or	skill-building.	For	legitimacy,	Boivin	and
colleagues	point	out	the	difference	between	statistical	representativeness	of	a	group	(correspondence	between
the	descriptive	characteristics	of	a	sample	and	those	of	the	population	from	which	they	are	drawn)	and
representation.	The	former	is	difficult	and	expensive;	the	latter,	where	individuals	speak	for	a	wider	constituency,
is	feasible	through	appropriate	connections,	for	example	access	to	community	groups	or	related	data.	To	achieve
a	balance	of	power,	facilitation	can	be	critical,	helping	with	seemingly	simple	strategies	like	seating	plans	and
titles,	as	well	as	ground	rules	and	agenda-setting.
Learn	as	we	go
We	need	to	study	co-production	as	a	topic,	over	and	above	the	focus	of	the	research	in	which	it	is	used.	Ideally,
those	involved	in	co-productive	research	will:
1.	 Draw	on	the	plentiful,	useful	but	largely	dispersed	literature	that	can	provide	evidence	for	what	works	where.
2.	 Use	an	existing	framework	and	model.
3.	 Commit	to	the	study	of	their	initiative	–	for	example	testing	the	adopted	framework	–	for	the	benefit	of	the
field.	Rather	than	more	lists	of	barriers	and	facilitators,	we	need	studies	of	co-production	in	action.
Conclusion
Of	course,	co-produced	research	will	ultimately	only	be	as	successful	as	the	broader	system	enables	it	to	be.
Funders	and	health	care	and	academic	organisations	also	have	a	role	to	play	(see	my	blog	post	with	Allan	Best,
“Six	actions	to	mobilise	knowledge	in	complex	systems“).
What	has	your	experience	been	with	research	co-production?	Can	you	point	to	useful	theories,	models,
frameworks	and	methods?
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reposted	here	with	permission.
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